Flavonoids, Breast Cancer Prevention, and Its Treatment: A Growing Evidence

References (80)

1. 1 Advances in flavonoid research since 1992 [DOI]
2. 2 Flavonoid Biosynthesis. A Colorful Model for Genetics, Biochemistry, Cell Biology, and Biotechnology [DOI]
3. 3 The biochemistry and medical significance of the flavonoids [DOI]
4. 4 A multidrug resistance transporter from human MCF-7 breast cancer cells [DOI]
5. 5 Flavonoids as antioxidants in plants: Location and functional significance [DOI]
6. 6 Interactions of Flavonoids with Iron and Copper Ions: A Mechanism for their Antioxidant Activity [DOI]
7. 7 Chelating and free radical scavenging mechanisms of inhibitory action of rutin and quercetin in lipid peroxidation [DOI]
8. 8 The different roles of ER subtypes in cancer biology and therapy [DOI]
9. 9 Flavonoids-potent and versatile biologically active compounds interacting with cytochromes P450 [DOI]
10. 10 Flavonoids: Dietary occurrence and biochemical activity [DOI]
11. 11 Induction of Cancer Cell Apoptosis by Flavonoids Is Associated with Their Ability to Inhibit Fatty Acid Synthase Activity [DOI]
12. 12 Relationship Between Estrogen Levels, Use of Hormone Replacement Therapy, and Breast Cancer [DOI]
13. 13 Antioxidant and Chelating Properties of Flavonoids [DOI]
14. 14 Induction of cell cycle arrest and apoptosis in human breast cancer cells by quercetin [DOI]
15. 15 Antiproliferative Activities of Citrus Flavonoids against Six Human Cancer Cell Lines [DOI]
16. 16 Flavonoids Are Inhibitors of Breast Cancer Resistance Protein (ABCG2)-Mediated Transport [DOI]
17. 17 Tissue injury by reactive oxygen species and the protective effects of flavonoids [DOI]
18. 18 Phytoestrogens/Flavonoids Reverse Breast Cancer Resistance Protein/ABCG2-Mediated Multidrug Resistance [DOI]
19. 19 Flavonoid–drug interactions: Effects of flavonoids on ABC transporters [DOI]
20. 20 Statins and breast cancer prognosis: evidence and opportunities [DOI]
21. 21 Childhood Soy Intake and Breast Cancer Risk in Asian American Women [DOI]
22. 22 Dietary flavonoid intake and risk of cancer in postmenopausal women: The Iowa Women's Health Study [DOI]
23. 23 The Role of Flavonoids on Oxidative Stress in Epilepsy [DOI]
24. 24 Quercetin is a potent anti‐atherosclerotic compound by activation of SIRT1 signaling under oxLDL stimulation [DOI]
25. 25 Total dietary antioxidant capacity, individual antioxidant intake and breast cancer risk: The R otterdam study [DOI]
26. 26 Dietary phytoestrogen intake—lignans and isoflavones—and breast cancer risk (Canada) [DOI]
27. 27 Identification of novel dietary phytochemicals inhibiting the efflux transporter breast cancer resistance protein (BCRP/ABCG2) [DOI]
28. 28 Troxerutin, a plant flavonoid, protects cells against oxidative stress-induced cell death through radical scavenging mechanism [DOI]
29. 29 Enzymatic antioxidants and its role in oral diseases [DOI]
30. 30 Black Tea Polyphenols: A Mechanistic Treatise [DOI]
31. 31 Phase I trial of continuous infusion flavopiridol, a novel cyclin-dependent kinase inhibitor, in patients with refractory neoplasms. [DOI]
32. 32 Phytoestrogen Consumption and Breast Cancer Risk in a Multiethnic Population: The Bay Area Breast Cancer Study [DOI]
33. 33 Urinary excretion of isoflavonoids and the risk of breast cancer.
34. 34 Phytoestrogens and breast cancer –promoters or protectors? [DOI]
35. 35 Phenoxodiol – an isoflavone analog – induces apoptosis in chemoresistant ovarian cancer cells [DOI]
36. 36 Chemoprevention studies of the flavonoids quercetin and rutin in normal and azoxymethane-treated mouse colon [DOI]
37. 37 Flavonoid intake and breast cancer risk: a case–control study in Greece [DOI]
38. 38 HER2-Positive Breast Cancer [DOI]
39. 39 Inhibition of proteasome activity by the dietary flavonoid apigenin is associated with growth inhibition in cultured breast cancer cells and xenografts [DOI]
40. 40 Dietary flavonoid fisetin targets caspase-3-deficient human breast cancer MCF-7 cells by induction of caspase-7-associated apoptosis and inhibition of autophagy [DOI]
41. 41 Flavonoids inhibit breast cancer resistance protein-mediated drug resistance: transporter specificity and structure–activity relationship [DOI]
42. 42 Antioxidative action of flavonoids, quercetin and catechin, mediated by the activation of glutathione peroxidase.
43. 43 Luteolin induces apoptosis in multidrug resistant cancer cells without affecting the drug transporter function: Involvement of cell line‐specific apoptotic mechanisms [DOI]
44. 44 Induction of Apoptosis by Icariside II through Extrinsic and Intrinsic Signaling Pathways in Human Breast Cancer MCF7 Cells [DOI]
45. 45 Flavonoid Phytochemicals Regulate Activator Protein-1 Signal Transduction Pathways in Endometrial and Kidney Stable Cell Lines [DOI]
46. 46 Dietary consumption of phytochemicals and breast cancer risk in Mexican women [DOI]
47. 47 Evidence for an Association of Dietary Flavonoid Intake with Breast Cancer Risk by Estrogen Receptor Status Is Limited [DOI]
48. 48 Phytoestrogens as natural prodrugs in cancer prevention: dietary flavonoids [DOI]
49. 49 Triticuside A, a Dietary Flavonoid, Inhibits Proliferation of Human Breast Cancer Cells Via Inducing Apoptosis [DOI]
50. 50 Phytoestrogens and Indicators of Breast Cancer Prognosis [DOI]
51. 51 Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries [DOI]
52. 52 The molecular biology of cytochrome P450s. [DOI]
53. 53 HER2-positive breast cancer [DOI]
54. 54 The Flavonoid Biosynthesis Network in Plants [DOI]
55. 55 Planning for tomorrow: global cancer incidence and the role of prevention 2020–2070 [DOI]
56. 56 Bioactive flavonoids in medicinal plants: Structure, activity and biological fate [DOI]
57. 57 Breast cancer: Biology, biomarkers, and treatments [DOI]
58. 58 Flavonoid biosynthetic pathways in plants: Versatile targets for metabolic engineering [DOI]
59. 59 Inhibition of human breast cancer cell proliferation and delay of mammary tumorigenesis by flavonoids and citrus juices [DOI]
60. 60 Molecular Subtypes and Local-Regional Control of Breast Cancer [DOI]
61. 61 Mutant p53 in breast cancer: potential as a therapeutic target and biomarker [DOI]
62. 62 Adolescent and adult soy food intake and breast cancer risk: results from the Shanghai Women’s Health Study [DOI]
63. 63 Steroid hormone activity of flavonoids and related compounds [DOI]
64. 64 Flavonoids and Breast Cancer Risk in Italy [DOI]
65. 65 Dietary Flavonoid Intake and Breast Cancer Risk among Women on Long Island [DOI]
66. 66 Lifestyle modifications for patients with breast cancer to improve prognosis and optimize overall health [DOI]
67. 67 Role of ATP-binding cassette transporters in cancer initiation and progression [DOI]
68. 68 Alleviation of Multidrug Resistance by Flavonoid and Non-Flavonoid Compounds in Breast, Lung, Colorectal and Prostate Cancer [DOI]
69. 69 Effects and mechanisms of dietary bioactive compounds on breast cancer prevention [DOI]
70. 70 Commonly occurring plant flavonoids have estrogenic activity. [DOI]
71. 71 Dietary flavonols quercetin and kaempferol are ligands of the aryl hydrocarbon receptor that affect CYP1A1 transcription differentially [DOI]
72. 72 Apigenin, a dietary flavonoid, induces apoptosis, DNA damage, and oxidative stress in human breast cancer MCF-7 and MDA MB-231 cells [DOI]
73. 73 Association between the Dietary Inflammatory Index and Risk for Cancer Recurrence and Mortality among Patients with Breast Cancer [DOI]
74. 74 Ki‐67 index, progesterone receptor expression, histologic grade and tumor size in predicting breast cancer recurrence risk: A consecutive cohort study [DOI]
75. 75 Association between flavonoids, flavonoid subclasses intake and breast cancer risk: a case-control study in China [DOI]
76. 76 Flavonoids Overcome Drug Resistance to Cancer Chemotherapy by Epigenetically Modulating Multiple Mechanisms [DOI]
77. 77 Biosynthesis of Diverse Class FlavonoidsviaShikimate and Phenylpropanoid Pathway [DOI]
78. 78 Human CYP1A1 inhibition by flavonoids [DOI]
79. 79 Inhibition of Neoplastic Transformation and Bioavailability of Dietary Flavonoid Agents [DOI]
80. 80 10.5530/jyp.2015.3 [DOI]

Cited by 0

No indexed citations yet.

Related research

• Trace Elements, Antioxidants, Uric Acid, C-Reactive Proteins and Estrogen Levels of Preeclamptic Pregnant Women in Owerri, Nigeria — shares topic coverage
• Effects of Selected Antioxidants on Atherosclerosis in Hyperlipidemic Wistar Rats — shares topic coverage
• Study of Antioxidants Vitamin E and Ascorbic Acid level in Pre-eclampsia and Normotensive Pregnant Women Attending the Antenatal Department of a Rural Hospital in Imo State South East Nigeria — shares topic coverage
• Antioxidant Protection Mechanisms in the Cardiovascular System — shares topic coverage
• Evaluation of Antioxidants, and Haematological Indices in Glaucoma Patients: A Case Study of Bayelsa State, Nigeria — shares topic coverage